These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

665 related articles for article (PubMed ID: 32032607)

  • 1. Nrf2 activator via interference of Nrf2-Keap1 interaction has antioxidant and anti-inflammatory properties in Parkinson's disease animal model.
    Kim S; Indu Viswanath AN; Park JH; Lee HE; Park AY; Choi JW; Kim HJ; Londhe AM; Jang BK; Lee J; Hwang H; Lim SM; Pae AN; Park KD
    Neuropharmacology; 2020 May; 167():107989. PubMed ID: 32032607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel compound VSC2 has anti-inflammatory and antioxidant properties in microglia and in Parkinson's disease animal model.
    Lee JA; Kim JH; Woo SY; Son HJ; Han SH; Jang BK; Choi JW; Kim DJ; Park KD; Hwang O
    Br J Pharmacol; 2015 Feb; 172(4):1087-100. PubMed ID: 25297649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct Nrf2 Signaling Mechanisms of Fumaric Acid Esters and Their Role in Neuroprotection against 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Induced Experimental Parkinson's-Like Disease.
    Ahuja M; Ammal Kaidery N; Yang L; Calingasan N; Smirnova N; Gaisin A; Gaisina IN; Gazaryan I; Hushpulian DM; Kaddour-Djebbar I; Bollag WB; Morgan JC; Ratan RR; Starkov AA; Beal MF; Thomas B
    J Neurosci; 2016 Jun; 36(23):6332-51. PubMed ID: 27277809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isoflavone biochanin A, a novel nuclear factor erythroid 2-related factor 2 (Nrf2)-antioxidant response element activator, protects against oxidative damage in HepG2 cells.
    Liang F; Cao W; Huang Y; Fang Y; Cheng Y; Pan S; Xu X
    Biofactors; 2019 Jul; 45(4):563-574. PubMed ID: 31131946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ginnalin A Binds to the Subpockets of Keap1 Kelch Domain To Activate the Nrf2-Regulated Antioxidant Defense System in SH-SY5Y Cells.
    Zhang Z; Peng L; Fu Y; Wang W; Wang P; Zhou F
    ACS Chem Neurosci; 2021 Mar; 12(5):872-882. PubMed ID: 33571414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of 2-oxy-2-phenylacetic acid substituted naphthalene sulfonamide derivatives as potent KEAP1-NRF2 protein-protein interaction inhibitors for inflammatory conditions.
    Lu MC; Shao HL; Liu T; You QD; Jiang ZY
    Eur J Med Chem; 2020 Dec; 207():112734. PubMed ID: 32866756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safranal prevents rotenone-induced oxidative stress and apoptosis in an in vitro model of Parkinson's disease through regulating Keap1/Nrf2 signaling pathway.
    Pan PK; Qiao LY; Wen XN
    Cell Mol Biol (Noisy-le-grand); 2016 Dec; 62(14):11-17. PubMed ID: 28145852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nuclear factor (erythroid-derived 2)-like 2 (NRF2) drug discovery: Biochemical toolbox to develop NRF2 activators by reversible binding of Kelch-like ECH-associated protein 1 (KEAP1).
    Bresciani A; Missineo A; Gallo M; Cerretani M; Fezzardi P; Tomei L; Cicero DO; Altamura S; Santoprete A; Ingenito R; Bianchi E; Pacifici R; Dominguez C; Munoz-Sanjuan I; Harper S; Toledo-Sherman L; Park LC
    Arch Biochem Biophys; 2017 Oct; 631():31-41. PubMed ID: 28801166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Multifunctional (-)-Meptazinol-Serotonin Hybrid Ameliorates Oxidative Stress-Associated Apoptotic Neuronal Death and Memory Deficits via Activating the Nrf2/Antioxidant Enzyme Pathway.
    Zhao F; Zhao L; Zhou Y; Tan X; Yang Y; Ni W; Zheng W; Chen H; Qiu Y; Li J
    Oxid Med Cell Longev; 2023; 2023():6935947. PubMed ID: 36819782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and optimization of piperine analogues as neuroprotective agents for the treatment of Parkinson's disease via the activation of Nrf2/keap1 pathway.
    Wang L; Cai X; Shi M; Xue L; Kuang S; Xu R; Qi W; Li Y; Ma X; Zhang R; Hong F; Ye H; Chen L
    Eur J Med Chem; 2020 Aug; 199():112385. PubMed ID: 32402936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of Keap1-Nrf2 small-molecule inhibitors from phytochemicals based on molecular docking.
    Li M; Huang W; Jie F; Wang M; Zhong Y; Chen Q; Lu B
    Food Chem Toxicol; 2019 Nov; 133():110758. PubMed ID: 31412289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and optimization of halogenated vinyl sulfones as Nrf2 activators for the treatment of Parkinson's disease.
    Choi JW; Kim S; Yoo JS; Kim HJ; Kim HJ; Kim BE; Lee EH; Lee YS; Park JH; Park KD
    Eur J Med Chem; 2021 Feb; 212():113103. PubMed ID: 33387904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CPUY192018, a potent inhibitor of the Keap1-Nrf2 protein-protein interaction, alleviates renal inflammation in mice by restricting oxidative stress and NF-κB activation.
    Lu MC; Zhao J; Liu YT; Liu T; Tao MM; You QD; Jiang ZY
    Redox Biol; 2019 Sep; 26():101266. PubMed ID: 31279986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The anti-inflammatory and anti-oxidative effect of a classical hypnotic bromovalerylurea mediated by the activation of NRF2.
    Takeda H; Nakajima Y; Yamaguchi T; Watanabe I; Miyoshi S; Nagashio K; Sekine H; Motohashi H; Yano H; Tanaka J
    J Biochem; 2023 Jul; 174(2):131-142. PubMed ID: 37039781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. S-allylmercaptocysteine ameliorates lipopolysaccharide-induced acute lung injury in mice by inhibiting inflammation and oxidative stress via nuclear factor kappa B and Keap1/Nrf2 pathways.
    Mo M; Li S; Dong Z; Li C; Sun Y; Li A; Zhao Z
    Int Immunopharmacol; 2020 Apr; 81():106273. PubMed ID: 32070920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of a head-to-tail cyclic peptide as the Keap1-Nrf2 protein-protein interaction inhibitor with high cell potency.
    Lu MC; Jiao Q; Liu T; Tan SJ; Zhou HS; You QD; Jiang ZY
    Eur J Med Chem; 2018 Jan; 143():1578-1589. PubMed ID: 29117896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The principal molecular mechanisms behind the activation of Keap1/Nrf2/ARE pathway leading to neuroprotective action in Parkinson's disease.
    Chakkittukandiyil A; Sajini DV; Karuppaiah A; Selvaraj D
    Neurochem Int; 2022 Jun; 156():105325. PubMed ID: 35278519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gallic acid, a natural polyphenol, protects against tert-butyl hydroperoxide- induced hepatotoxicity by activating ERK-Nrf2-Keap1-mediated antioxidative response.
    Feng RB; Wang Y; He C; Yang Y; Wan JB
    Food Chem Toxicol; 2018 Sep; 119():479-488. PubMed ID: 29066411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Keap1-Nrf2-ARE Pathway As a Potential Preventive and Therapeutic Target: An Update.
    Lu MC; Ji JA; Jiang ZY; You QD
    Med Res Rev; 2016 Sep; 36(5):924-63. PubMed ID: 27192495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ferulic Acid Ameliorates MPP
    Li X; Zhang J; Rong H; Zhang X; Dong M
    Mol Neurobiol; 2020 Jul; 57(7):2981-2995. PubMed ID: 32445087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.